Akt pathway is required for oestrogen-mediated attenuation of lung injury in a rodent model of cerulein-induced acute pancreatitis

Injury. 2011 Jul;42(7):638-42. doi: 10.1016/j.injury.2010.07.242. Epub 2010 Aug 14.

Abstract

Background: The phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) is known to be an endogenous negative feedback or compensatory mechanism that serves to limit pro-inflammatory and chemotactic events in response to injury. The aim of this study is to elucidate whether Akt plays any role in 17β-estradiol (E2)-mediated attenuation of lung injury after acute pancreatitis (AP).

Materials and methods: Male Sprague-Dawley rats underwent cerulein-induced AP. Rats were treated with vehicle (cyclodextrin), E2 (1 mg/kg body weight [BW]), or E2 plus PI3K/Akt inhibitor Wortmannin (100 μg/kg BW) 1h after the onset of AP. At 8 h after sham operation or AP, various parameters were measured.

Results: AP led to a significant decrease in lung Akt phosphorylation, which was associated with increased lung tissue myeloperoxidase (MPO) activity, wet-to-dry weight ratios, interleukin (IL)-6, tumor necrosis factor (TNF)-α, cytokine-induced neutrophil chemoattractant (CINC)-1, and CINC-3 levels. Administration of E2 after AP restored the AP-induced decrease in Akt phosphorylation and attenuated the increase in lung injury markers (MPO activity and wet-to dry weight ratios) and pro-inflammatory mediator production. The effects of E2 on the lung were abolished by co-administration of Wortmannin.

Conclusions: These results collectively suggest evidences that the Akt pathway seems to be required for E2-mediated protection of lung injury after AP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androstadienes / pharmacology
  • Animals
  • Blotting, Western
  • Ceruletide
  • Chemokine CXCL1 / metabolism
  • Chemokine CXCL2 / metabolism
  • Cyclodextrins / pharmacology
  • Estradiol / pharmacology*
  • Interleukin-6 / metabolism
  • Lung Injury / chemically induced
  • Lung Injury / drug therapy
  • Lung Injury / metabolism*
  • Male
  • Pancreatitis / chemically induced
  • Pancreatitis / drug therapy
  • Pancreatitis / metabolism*
  • Peroxidase / metabolism
  • Phosphorylation
  • Proto-Oncogene Proteins c-akt / antagonists & inhibitors
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Tumor Necrosis Factor-alpha / metabolism
  • Wortmannin

Substances

  • Androstadienes
  • Chemokine CXCL1
  • Chemokine CXCL2
  • Cxcl1 protein, rat
  • Cxcl2 protein, rat
  • Cyclodextrins
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Estradiol
  • Ceruletide
  • Peroxidase
  • Akt3 protein, rat
  • Proto-Oncogene Proteins c-akt
  • Wortmannin